← EPO Patent Bulletin

CONTINUOUS ADMINISTRATION OF VITAMIN B12 FOR THE TREATMENT OF CEREBROVASCULAR DISEASE OR CENTRAL NERVE INJURY

Publication EP3730144A1 Kind: A1 Mar 18, 2026

Applicants

Osaka University, Nippon Zoki Pharmaceutical Co., Ltd.

Inventors

TANAKA, Hiroyuki, YOSHIKAWA, Hideki, MOCHIZUKI, Hideki, MURASE, Tsuyoshi, SASAKI, Tsutomu, BABA, Kousuke, IWAHASHI, Toru, NAIKI, Mitsuru

Abstract

An object is to provide a drug which is useful in treating a nervous system disease. A drug containing vitamin B<sub>12</sub>as an active ingredient according to the present invention has an M2 macrophage/microglia induction promoting effect, an M1 macrophage/microglia induction inhibiting effect, a nerve regeneration promoting effect, and the like and is very useful as a therapeutic agent for a nervous system disease, and particularly useful as a therapeutic agent for a central nervous system disease such as cerebral infarction, dementia, or spinal cord injury.

IPC Classifications

A61K 31/714 20060101AFI20260202BHEP A61K 9/08 20060101ALI20260202BHEP A61P 7/02 20060101ALI20260202BHEP A61P 9/00 20060101ALI20260202BHEP A61P 9/10 20060101ALI20260202BHEP A61P 25/00 20060101ALI20260202BHEP A61P 25/28 20060101ALI20260202BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR